BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33542203)

  • 1. HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target.
    Cheng C; Yang J; Li SW; Huang G; Li C; Min WP; Sang Y
    Cell Death Dis; 2021 Feb; 12(2):137. PubMed ID: 33542203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma.
    Sun X; Zhang K; Peng X; Zhou P; Qu C; Yang L; Shen L
    Cancer Lett; 2023 May; 562():216158. PubMed ID: 37023940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma.
    Zeng LS; Yang XZ; Wen YF; Mail SJ; Wang MH; Zhang MY; Zheng XF; Wang HY
    Aging (Albany NY); 2016 Jun; 8(6):1236-49. PubMed ID: 27295551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase HDAC4 promotes the proliferation and invasion of glioma cells.
    Cai JY; Xu TT; Wang Y; Chang JJ; Li J; Chen XY; Chen X; Yin YF; Ni XJ
    Int J Oncol; 2018 Dec; 53(6):2758-2768. PubMed ID: 30272277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis.
    Li QG; Xiao T; Zhu W; Yu ZZ; Huang XP; Yi H; Lu SS; Tang YY; Huang W; Xiao ZQ
    Cell Death Dis; 2020 May; 11(5):322. PubMed ID: 32376822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1.
    Chen WH; Cai MY; Zhang JX; Wang FW; Tang LQ; Liao YJ; Jin XH; Wang CY; Guo L; Jiang YG; Ren CP; Mai HQ; Zeng MS; Kung HF; Qian CN; Xie D
    Oncogene; 2018 Nov; 37(48):6243-6258. PubMed ID: 30013189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo.
    Song Q; Zhang H; Wang M; Song W; Ying M; Fang Y; Li Y; Chao Y; Zhu X
    J Exp Clin Cancer Res; 2013 Aug; 32(1):54. PubMed ID: 23941622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma.
    He S; Yang S; Niu M; Zhong Y; Dan Gao ; Zhang Y; Ma H; Xiong W; Zhou M; Zhou Y; Xiang B; Li G; Shuai C; Peng S
    Cell Death Dis; 2018 Jan; 9(2):100. PubMed ID: 29367693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment.
    Isaacs JT; Antony L; Dalrymple SL; Brennen WN; Gerber S; Hammers H; Wissing M; Kachhap S; Luo J; Xing L; Björk P; Olsson A; Björk A; Leanderson T
    Cancer Res; 2013 Feb; 73(4):1386-99. PubMed ID: 23149916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.
    Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G
    J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
    Zhang X; Qi Z; Yin H; Yang G
    Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling.
    Qiu WZ; Zhang HB; Xia WX; Ke LR; Yang J; Yu YH; Liang H; Huang XJ; Liu GY; Li WZ; Xiang YQ; Kang TB; Guo X; Lv X
    J Exp Clin Cancer Res; 2018 Apr; 37(1):85. PubMed ID: 29665837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of prostate stem cell antigen (PSCA) by Slug promotes metastasis in nasopharyngeal carcinoma.
    Wang L; Sang Y; Tang J; Zhang RH; Luo D; Chen M; Deng WG; Kang T
    J Pathol; 2015 Dec; 237(4):411-22. PubMed ID: 26147638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
    Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
    FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.